Laboratory testing in hemophilia: Impact of factor and non‐factor replacement therapy on coagulation assays-Reference-Cited by-同舟云学术

Laboratory testing in hemophilia: Impact of factor and non‐factor replacement therapy on coagulation assays

Published:2020-04-23 Issue:6 Volume:18 Page:1242-1255
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Peyvandi Flora¹²,Kenet Gili³⁴,Pekrul Isabell⁵,Pruthi Rajiv K.⁶⁷^ORCID,Ramge Peter⁸,Spannagl Michael⁵

Affiliation:

1. Department of Pathophysiology and Transplantation Università degli Studi di Milano Milan Italy

2. Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

3. Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

4. The Israeli National Hemophilia Center and Thrombosis Unit The Amalia Biron Thrombosis Research Institute Sheba Medical Center Tel Hashomer Israel

5. Hämostaseologie, Campus Innenstadt Klinikum der Universität München München Germany

6. Division of Hematology Department of Internal Medicine Mayo Clinic Rochester Rochester MN USA

7. Division of Hematopathology and Laboratory Genetics Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Rochester MN USA

8. Roche Diagnostics International Ltd Rotkreuz Switzerland

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14784

Reference86 articles.

1. Guidelines for the management of hemophilia

2. AHCDO/NBA.Guidelines for the management of haemophilia in Australia (Australian Haemophilia Centre Directors’ Organisation and National Blood Authority).2018.

3. NHC.nordic hemophilia guidelines (Nordic Hemophilia Council).2017.

4. Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hämophilie – Revolution der Therapiemöglichkeiten?;Die Innere Medizin;2024-08-30

2. Clinical and Humanistic Burden of Non-inhibitor Haemophilia A in Five European Countries: Insights from the CHESS II Study;Advances in Therapy;2024-08-17

3. Evaluating Factor VIII Concentrates Using Clot Waveform Analysis;Journal of Clinical Medicine;2024-06-30

4. Strategies for Performing Factor Assays in the Presence of Emicizumab or Other Novel/Emerging Hemostatic Agents;Seminars in Thrombosis and Hemostasis;2024-06-12

5. Genetics and Epigenetics in Acquired Hemophilia A: From Bench to Bedside;Current Issues in Molecular Biology;2024-05-23